Streetwise Reports' Article Archives — March 2023 back to current month (11)
New Treatment for Ovarian Cancer Shows Promise (03/30/2023)
Additional trial data also show efficacy of this investigative combination treatment in a difficult to treat patient population, noted an H.C. Wainwright & Co. report.
Telehealth Co. Signs Largest Client Yet (03/30/2023)
Onboarding will begin in April for the healthcare system that has more than 1,200 care centers in seven states.
Coverage Launched on Drug Co. With 140% Upside (03/29/2023)
The Canadian specialty pharma, with a proven track record of in-licensing and acquiring late-stage assets, is "poised to grow meaningfully in the coming years," noted an Echelon Capital Markets report.
Trial of New Ophthalmic Drug Now Enrolled (03/29/2023)
More than the target number of patients was enrolled in this Phase 2 study of an investigative treatment for a serious eye disease, noted an H.C. Wainwright & Co. report.
FDA Approval of New Gout Drug Likely, Analyst Says (03/27/2023)
Despite a competitor already on the market, the commercial opportunity for this particular treatment is strong, given its advantages, noted a BTIG report.
Biotech Improves Efficiency of Its New Immunotherapy (03/22/2023)
The enhancements the company made to its investigative therapy that uses a patient's own immune cells were independently validated, noted a ROTH research report.
Former NFL Safety Director Joins Neurotherapy Firm Advisory Board (03/21/2023)
Treating traumatic brain injury with alternative pharmaceuticals is delicate work. Now one Canadian firm has enlisted the help of former National Football League Neurological Player Care Safety Director Dr. David Brody.
Coverage Launched on Canadian Specialty Pharma Co. (03/15/2023)
This company can further grow its product portfolio and revenues and, thus, boost its operating leverage, but these capabilities "remain underappreciated by investors," noted an Echelon Capital Markets report.
Telemedicine Co. Sees Record Revenues on Software, Services Sales (03/13/2023)
Reliq Health Technologies Inc. reports that software and services revenue continues to increase, leading to record cash intake for the quarter that ended Dec. 31, 2022.
Blockchain Co. Launches Digital Coupon Consumer App (03/08/2023)
Global Compliance Applications Corp. is launching a new app that will enable consumers to receive and share digital token coupons and store them in digital wallets.
New Skin Gene Therapy Gets PDUFA Date (03/01/2023)
The future of this investigational treatment for dystrophic epidermolysis bullosa looks positive, with full approval and subsequent successful commercial launch expected, noted an H.C. Wainwright & Co. report.
More Archives
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
